Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
DoP issues grievance note about online promotion during COVID-19 crisis
Instructs pharma associations to ensure that member companies follow ethical practices for brand promotion, especially during…
HP initiates work on Bulk Drug Park, acquires 1000 bigha land
The State Governor constitutes a nine-member committee to take concrete steps towards setting up the bulk drugs park
Videojet upgrades the 9550 Label Print and Apply (LPA) system with a new 6” printhead option
Innovatively designed, Videojet® 9550 LPA system increases reliability, efficiency and productivity for outer case and bundle…
IISc and TalentSprint partner to launch multiple executive programs in emerging and disruptive…
The program is ideal for current and aspiring professionals in Clinical Data Science, Biotechnology, Pharmaceuticals, InsureTech,…
Indoco receives US FDA approval for Succinylcholine Chloride Injection USP
Succinylcholine Chloride Injection is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to…
Treatment for a form of bladder dysfunction in pediatric patients approved by the US FDA
The efficacy of VESIcare LS for the treatment of neurogenic detrusor overactivity (NDO) was established in two clinical trials…
Pharma software development less disrupted by COVID-19: GlobalData
It is taking advantage of new niches like delivering applications for tracking and monitoring the spread of the disease
US FDA approves the only drug in US to treat severe malaria
Prior to this approval, IV artesunate was only available to patients through the FDA’s Expanded Access program
Biocon Biologics gets DCGI approval for emergency use of CytoSorb to treat critical COVID-19…
US FDA recently approved CytoSorb for emergency use in COVID-19 patients
FICCI submits recommendations to government for regulatory reforms in pharma
The recommendations comprise improvement proposals for new drug registrations; animal toxicity and testing, clinical trials; and…